P-D5 Synthesis and characterization of core-–shell silica cobalt ferrite nanoparticles as a first step towards developing ultrasensitive MRI probes for long-acting antiretroviral drug biodistribution testing. (March 2017)
- Record Type:
- Journal Article
- Title:
- P-D5 Synthesis and characterization of core-–shell silica cobalt ferrite nanoparticles as a first step towards developing ultrasensitive MRI probes for long-acting antiretroviral drug biodistribution testing. (March 2017)
- Main Title:
- P-D5 Synthesis and characterization of core-–shell silica cobalt ferrite nanoparticles as a first step towards developing ultrasensitive MRI probes for long-acting antiretroviral drug biodistribution testing
- Authors:
- Kevadiya, Bhavesh
Bade, Aditya
Woldstad, Christopher
Boska, Michael
Edagwa, Benson
Mcmillan, Joellyn
Gendelman, Howard - Abstract:
- Abstract : Cobalt ferrite (CF) nanoparticles were developed as magnetic resonance (MR) imaging contrast agents. However, its size, shape and chemical features also make the particles applicable for screening biodistribution of drug carriers. In developing long-acting nanoformulated antiretroviral drugs (ARVs), CF provides unique translational prospects. Thus, we investigated whether europium (Eu) doped CF nanoparticles (CFEu) could be useful in screening of nanoparticle ARVs. CFEus were synthesized by a modified solvothermal technique and functionalized with core-shell-Pluronic®F-127 (Si-CFEu). The synthesized superparamagnetic, monodispersed CFEus were highly crystalline with an inverse-spinel structure. The particle size was 7.2 nm and 140 nm for CFEu and Si-CFEu, respectively. Folic acid (FA) decoration onto the surface of the Si-CFEu facilitated mononuclear phagocyte (MP) targeting. Uptake and retention of FA-Si-CFEu nanoparticles by MP were demonstrated. The presence of intracellular particles was made by prussian blue and confocal microscopy confirming the ultrahigh transverse relaxivity (r 2 = 7917.9 s/mL/μg) measurements. To simulate immune activation of HIV-1- infected person, rats were treated with 2 mg/kg lipopolysaccharide (LPS). MRI scans demonstrated increase in T2 and decrease in signal in the reticuloendothelial system of the LPS treated rats 24 hours post-injection of Si-CFEu and FA-Si-CFEu. FA-Si-CFEu particles provided significantly higher tissue ironAbstract : Cobalt ferrite (CF) nanoparticles were developed as magnetic resonance (MR) imaging contrast agents. However, its size, shape and chemical features also make the particles applicable for screening biodistribution of drug carriers. In developing long-acting nanoformulated antiretroviral drugs (ARVs), CF provides unique translational prospects. Thus, we investigated whether europium (Eu) doped CF nanoparticles (CFEu) could be useful in screening of nanoparticle ARVs. CFEus were synthesized by a modified solvothermal technique and functionalized with core-shell-Pluronic®F-127 (Si-CFEu). The synthesized superparamagnetic, monodispersed CFEus were highly crystalline with an inverse-spinel structure. The particle size was 7.2 nm and 140 nm for CFEu and Si-CFEu, respectively. Folic acid (FA) decoration onto the surface of the Si-CFEu facilitated mononuclear phagocyte (MP) targeting. Uptake and retention of FA-Si-CFEu nanoparticles by MP were demonstrated. The presence of intracellular particles was made by prussian blue and confocal microscopy confirming the ultrahigh transverse relaxivity (r 2 = 7917.9 s/mL/μg) measurements. To simulate immune activation of HIV-1- infected person, rats were treated with 2 mg/kg lipopolysaccharide (LPS). MRI scans demonstrated increase in T2 and decrease in signal in the reticuloendothelial system of the LPS treated rats 24 hours post-injection of Si-CFEu and FA-Si-CFEu. FA-Si-CFEu particles provided significantly higher tissue iron concentration compared to Si-CFEu signifying targeting abilities. These data bring us one step closer towards using decorated Si- CFEu particles to assess biodistribution of nanoformulated ARVs. … (more)
- Is Part Of:
- Journal of acquired immune deficiency syndromes. Volume 74(2017)Supplement 3
- Journal:
- Journal of acquired immune deficiency syndromes
- Issue:
- Volume 74(2017)Supplement 3
- Issue Display:
- Volume 74, Issue 3 (2017)
- Year:
- 2017
- Volume:
- 74
- Issue:
- 3
- Issue Sort Value:
- 2017-0074-0003-0000
- Page Start:
- Page End:
- Publication Date:
- 2017-03
- Subjects:
- AIDS (Disease) -- Periodicals
Acquired Immunodeficiency Syndrome -- Periodicals
AIDS (Disease)
Periodicals
616.9792005 - Journal URLs:
- http://journals.lww.com/jaids/pages/default.aspx ↗
http://www.jaids.com ↗
http://journals.lww.com ↗ - DOI:
- 10.1097/01.qai.0000513995.89505.61 ↗
- Languages:
- English
- ISSNs:
- 1525-4135
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4644.422000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 4525.xml